Verax Biomedical, Inc.

Worcester, MA 01605

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.8MM
First Award Date 01/21/02
Most Recent Award Date 07/01/07

Key Personnel

Last Name Name Awards Contact
Hall Jeffrey Allen Hall 6

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-28
Budget: 07/01/07 - 06/30/08

DESCRIPTION (provided by applicant): Verax Biomedical Inc. proposes to develop a rapid, accurate, cost-effective screening test to detect a broad array of bacterial contaminants in stored human platelet concentrates for use near the time of transfusion. The risk of bacterial contamination is approximately 1 in 2000 transfusions, which makes it t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-28
Budget: 07/01/06 - 06/30/07

DESCRIPTION (provided by applicant): Verax Biomedical Inc. proposes to develop a rapid, accurate, cost-effective screening test to detect a broad array of bacterial contaminants in stored human platelet concentrates for use near the time of transfusion. The risk of bacterial contamination is approximately 1 in 2000 transfusions, which makes it t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/04 - 03/31/05

DESCRIPTION (provided by applicant): Verax Biomedical Inc. proposes to develop a rapid, accurate, cost-effective screening test to detect a broad array of bacterial contaminants in stored human platelet preparations. The risk of bacterial contamination is approximately 1 per 2,000 donations, which makes it the single greatest infectious risk in ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/03 - 03/31/04

DESCRIPTION (provided by applicant): Verax Biomedical Inc. proposes to develop a rapid, accurate, cost-effective screening test to detect a broad array of bacterial contaminants in stored human platelet preparations. The risk of bacterial contamination is approximately 1 per 2,000 donations, which makes it the single greatest infectious risk in ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/15/03 - 07/14/04

DESCRIPTION (provided by applicant): Verax Biomedical Inc proposes to develop a rapid, accurate, cost-effective screening test to detect a broad array of bacterial contaminants in stored human red blood cells. The risk of bacterial contamination is approximately 1 per 2,000 donations, which makes it the single greatest infectious risk in transfu...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/21/02 - 07/20/02

DESCRIPTION (provided by applicant): Verax Biomedical Inc. proposes to develop a rapid, accurate, cost-effective screening test to detect a broad array of bacterial contaminants in stored human platelets. The risk of bacterial contamination is approximately 1 per 2,000 donations, which makes it the single greates...